It is essential for new health information technologies (IT) to undergo rigorous evaluations to ensure they are effective and safe for use in real-world situations. However, evaluation of new health IT is challenging, as fi eld studies are often not feasible when the technology being evaluated is not suffi ciently mature. Laboratory-based evaluations have also been shown to have insuffi cient external validity. Simulation studies seem to be a way to bridge this gap. The aim of this study was to evaluate, using a simulation methodology, the impact of a new prototype of an electronic medication management system on the appropriateness of prescriptions and drugrelated activities, including laboratory test ordering or medication changes. This article presents the results of a controlled simulation study with 50 simulation runs, including ten doctors and fi ve simulation patients, and discusses experiences and lessons learnt while conducting the study. Although the new electronic medication management system showed tendencies to improve medication safety when compared with the standard system, this tendency was not signifi cant. Altogether, fi ve distinct situations were identifi ed where the new medication management system did help to improve medication safety. This simulation study provided a good compromise between internal validity and external validity. However, several challenges need to be addressed when undertaking simulation evaluations including: preparation of adequate test cases; training of participants before using unfamiliar applications; consideration of time, effort and costs of conducting the simulation; technical maturity of the evaluated system; and allowing adequate preparation of simulation scenarios and simulation setting. Simulation studies are an interesting but time-consuming approach, which can be used to evaluate newly developed health IT systems, particularly those systems that are not yet suffi ciently mature to undergo fi eld evaluation studies.
Introduction
New health information technologies (health IT) need to undergo thorough evaluations to assure they are effective and safe to be used in health care settings (Anderson & Goodman 2002; Brender 2006; Friedman & Wyatt 2006; Rigby et al. 2011 ). This also holds true for health IT that is used to support medication management. Medicationrelated adverse events are among the most common adverse events (European Commission 2008) . Health ITsupported medication management is seen as a possible means of increasing medication safety (Institute of Medicine 2006) . Several studies and systematic reviews have shown the possible benefit of health IT for medication safety (Bates et al. 1999; Westbrook et al. 2012; Ammenwerth et al. 2008) , while others pointed to limitations or even negative impact of IT-supported medication management (Baysari et al. 2011; Ash et al. 2009; Han et al. 2005) .
New approaches to improve medication safety have been investigated within the European project known as 'Patient Safety through Intelligent Procedure in Medication' (PSIP) (http://www.psip-project.eu). Among others, a contextualised clinical decision support system (CDSS) to support prescriptions at the point-ofcare has been developed. In this CDSS, rules have been implemented to provide specific alerts and information to clinicians, taking into account the clinical context as defined by hospital, department and user. The CDSS was integrated with existing hospital information systems, electronic prescribing tools and specialised web portals (Koutkias et al. 2009; Beuscart et al. 2009; Koutkias et al. 2010; Koutkias et al. 2011) . Within the PSIP project, summative evaluation activities to measure the impact of these prototypes on patient safety were planned. However, the developed prototypes were partly comprised of very new approaches, such as contextualised decision support, and not sufficiently stable and mature for clinical use or ready to undergo real field evaluation studies. Conversely, pure laboratory evaluation studies were not suitable either as they do not provide sufficient external validity, which is necessary for summative evaluations.
Thus, as laboratory studies are not adequate to evaluate the impact of a new technology, and because field studies were considered too risky, we decided to conduct a simulation study. The concept of 'simulation studies' describes studies in settings that are as close to routine care as possible, but without endangering patients and clinicians (Rossnagel 1998) . In instances such as this, simulation studies often include simulation patients who are trained to behave like 'real' patients. Simulation studies can be conducted in the daily workplace of the clinicians or in specially designed simulation wards that resemble a real ward, but where only simulation patients are treated. Simulation studies allow evaluation of the impact of innovative solutions that are not sufficiently mature to undergo a fully-fledged field study. A simulation study also provides a psychological safe space for the participant to try out new systems.
The concept of simulation has been successfully used for training medical students (Stefan et al. 2011; Okuda et al. 2009 ). However there are few published studies of its application as an evaluation strategy for impact evaluation of health IT. One available study describes a simulation study that evaluated the feasibility of digital signatures in a cooperative setting (Kumbruck & Schneider 1999) . Another used a simulation study to assess the impact of a new mobile clinical documentation and communication system in a hospital setting (Ammenwerth et al. 1999) , while yet another analysed staff-patient interaction during simulated emergency situations (Siassakos et al. 2011) . In all previous examples, the simulation study approach was found to be useful in combining a safe and partly controlled, yet quite realistic, environment. So we were optimistic that this approach would be feasible for a summative evaluation of the impact of the PSIP prototypes.
The objective of this study was to evaluate the impact of a new PSIP medication management system (named 'PSIP-DK') on the appropriateness of prescriptions and related clinical activities. The PSIP-DK is an electronic medication management system that offers integrated access to relevant clinical data (e.g. drug allergy information, diagnoses, laboratory values, recent prescriptions) and supports prescribing, including decision support for the doctor during the prescription process. This paper presents results and discusses experiences and lessons learnt while conducting the simulation study.
Methods

Study design
The study question of this simulation study was: Does the new medication management system PSIP-DK help to increase medication safety? In order to assess the impact of PSIP-DK on medication safety, we performed a controlled simulation study in 2010. Planning and preparation for the PSIP-DK test began six months prior to the evaluation. The simulation involved ten doctors and five patients. Overall, 50 simulation runs were performed (ten doctors, five patients). The number of test cases and participants were based on the practical limitations in laboratory access time and recruitment of doctors and actors to stand in for patients. No formal sample size calculation was performed.
To be able to directly assess the impact of the PSIP-DK prototype, we compared it with the standard medication management system used in the Capital Region in Denmark (called the 'standard system'). One half of the simulation runs were performed with the standard system and the other half with the PSIP-DK. To reduce the risk of bias, the simulation runs were organised in the following way:
Each doctor treated all five patients, using the 'standard system' for half of the patients (thus for either two or three patients), and the PSIP-DK for the remaining patients. Each patient participated in ten simulation runs (performed by ten doctors); in five runs, he/she was treated by the 'standard system'; in five cases, he/she was treated with the help of the PSIP-DK. Overall, 25 of the 50 simulation runs were done with the standard system, the other 25 with PSIP-DK. The 50 simulation runs were performed over a period of three days, with each doctor being active during half a day. Each simulation run was planned to take approximately 20 minutes, which turned out to be too short, as the average time spent on a simulation was 30 minutes (excluding several PSIP-DK prototype breakdowns).
The PSIP-DK prototype for medication management used in the simulation group
The technical setup in the simulations provided access to both the PSIP-DK prototype and the 'standard system' in both bedrooms 1 . The PSIP-DK prototype setup consisted of a laptop computer with the PSIP client installed and a separate server with the Clinical Decision Support System (CDSS). The prototype provided access to clinical data and supported prescriptions, including decision support to the doctor during the prescription process. Figure 1 shows the layout of the main screen of PSIP-DK (Nohr et al. 2011; Kanstrup et al. 2011) : The decision support provided to the doctor during the prescription process was realised by embedding responses regarding potential medication risks from the PSIP-DK CDSS based on the choices of drug to be prescribed and the conditions of the patient. A double click on an alert opens a pop-up window with additional information on the alert ( Figure  2) . If the doctor then wants to prescribe the selected drug(s), a standard and well-known screen to complete the prescription (dose, route etc.) opens.
The 'standard system' for medication management used in the control group
The 'standard system' operated in the way the clinicians were used to in their daily routines. The setup consisted of two applications: the local medication prescription system (EPM3) for viewing the patients' drug regime and entering prescriptions, and the Opus system for viewing diagnosis and patient notes. EPM3 offered standard alerting functionality as used in the Capital Region, which covers drug-drug interactions, double dose and allergies. Laboratory results were presented in a paper-based record, as the physicians were used to working with test results presented in this form as an alternative to accessing laboratory results within the Opus system. 
Research
The location and artefacts
A realistic setting is crucial for external validity of simulation studies. The location of the simulation study comprised two complete patient rooms, each fully equipped for simulations at the IT experimental laboratory at Herlev Hospital in Copenhagen (ITX). The ITX facilities are designed for clinical training and testing, consisting of a full-scale hospital ward with 13 bedrooms, an operating theatre and a fully equipped medicine room. Each bedroom has an adjoining observation room for instructing and controlling the simulations (see Figure 3) . Each bedroom was fitted with a ceiling-mounted remote controlled camera and two fixed cameras. Furthermore, the bedside computer at which the clinicians were working was connected to a screen capture setup, and an additional hand-held camera was used following the acting doctor close-up. Each bedroom was furnished with a complete set of clinical artifacts relevant for the scenarios. The 'patients' were dressed in patient's clothing, equipped with venous catheters, and placed in hospital beds or chairs. The participating doctors had access to laptop computers as well as to a paper record.
Other artifacts included white coat, stethoscope, and bedside flowers. During the simulations, a team member acted as the nurse and helped in case there were questions with regard to the patient case, which reflected the normal situation during a ward round. The coordinator could give instructions from the observation room to the nurse via a discrete intercom headset. The clinicians were able to use external knowledge tools such as drug information books or websites. They could also consult a senior doctor or a laboratory doctor via cell phone whenever needed. They received technical support if they experienced serious computer problems. Overall, the study team consisted of approximately 20 researchers and technicians who were responsible for the smooth flow of the simulations. A more detailed description of the simulation setting can be found in Lawton et al. (2011) .
The simulation scenarios
To create a realistic setting, the participating doctors were asked to perform a ward round on the five patients. They were told that it was Monday, and that there were five patients they had to take care of. They were asked to review the available clinical data, talk to the patients, decide on the next steps (e.g. new or modified prescription, laboratory orders) and document this. The doctors' chosen way of doing this showed wide differences: some would take time to make their preparations in front of the workstation, while others would go directly to the patient. A few doctors found the free choice of procedure a bit confusing.
The five patient cases were chosen for their complexity in order to exemplify the functionalities of the PSIP-DK prototype as well as for the inherent potential they had for doctors to make errors concerning prescription of medication. Naturally, the scenarios could not Research include deliberate instructions for doctors to engage in erroneous behaviours. However, a workshop produced a catalogue of possible features to include in the scenarios (Nohr et al. 2011) . Suitable test cases were selected from real cases where an adverse drug event (ADE) had occurred. These cases were identified by data mining in another hospital in the Capital Region, Frederiksberg Hospital, in earlier phases of the PSIP project. A specialist in internal medicine and patient safety (PS) reviewed these cases. Based on his estimate that the ADE were likely to be repeated in a simulation run, five cases were selected.
The scenarios were described in separate sub-scripts and included patient data such as name, social security number (the unique personal identifier) and age. The medical history included previous and current diagnosis, plan for treatment, medications, laboratory results, allergies and marital status. The scenarios also included clinical observations at the start of the simulation (e.g. temperature, dizziness, blood pressure). Furthermore, each scenario involved a short narrative in order to set the scene for the participating doctor and nurse. All scenarios are in the Danish language and are available upon request.
Recruitment of clinicians and patients
The participating clinicians were recruited through a written request mailed to the clinical administrators of six different departments of internal medicine throughout the Capital Region of Denmark. Payment for participation was 1000 DKK/€125 for three hours. Overall, from 12 recruited clinicians, 10 presented for the simulations. The doctors had no previous preparation before the day of the simulation. On arrival, they were introduced to ITX, the project and the simulation test. This introduction included hands-on trial of the PSIP prototype, to ensure doctors were familiar with the PSIP prototype.
The participating patients were recruited by the project team through their private networks. The five 'patients' were invited into ITX some weeks before commencing the simulation to be introduced to their roles. Each patient received a manuscript containing the facts and symptoms of their individual patient case in detail. The manuscripts did not contain any specific lines to which they had to adhere. In order to respond naturally to questions, they were asked to make up the answers the best they could from their knowledge of the condition and symptoms when examined during the simulations by the participating doctors. The assisting nurse was able to help if needed, which is similar to a real ward round.
Methods for data acquisition and data analysis
To assess the impact of the PSIP-DK, we defined an expected outcome as the gold standard. This gold standard was defined beforehand by two experienced Danish physicians based on the data from the five patient cases. This gold standard comprised a list of expected clinical activities that should be performed for the given patient. Table 1 presents the defined gold standard for each of the five patient cases (A -E). All user activities during the simulation were recorded as described above. A Danish physician, who had already participated in designing the gold standard, analysed these data to identify how many expected activities had been performed by each doctor in each simulation run. Based on this, the percentage of the fulfillment of the gold standard was calculated for each user. The study group and control group were compared using a t-test, with alpha set to .05.
In addition, a short, semi-structured debriefing interview was conducted by two researchers (CN, WH) with each physician to get the subjective opinion of the users with regard to the impact of PSIP-DK on patient safety. These interviews were audio recorded and transcribed. The interview transcripts complemented the results from the simulation runs as they were used to identify or confirm cases where the PSIP-DK had an impact on medication management, as seen from the point of view of the users. No formal qualitative analysis was conducted from the transcripts. Figure 4 shows the outcome for performance in both study groups. When performance was analysed for the doctors on an individual basis, four doctors performed better when using the PSIP-DK, three performed equally in both situations, and two performed better with the standard system (no formal statistical test was conducted due to low sample sizes). When junior doctors were compared with senior doctors, the performance of junior doctors was clearly better than that of senior doctors, and this difference was statistically significant. However, when performance data for junior doctors and senior doctors were examined separately, no statistically significant difference was found between their use of the PSIP-DK and the standard system.
Selected quantitative study fi ndings
Selected qualitative study fi ndings
By qualitatively analysing the video data and verifying these findings with data from the interview transcripts, five situations could be identified where a PSIP-DK alert did influence the decision of a doctor: 1. Doctor 3 started to prescribe an antibiotic drug and received an alert regarding renal insufficiency. As a reaction, she chose another antibiotic and reviewed whether this changed the alert. PSIP-DK was used here, as intended, to simulate the outcome of different prescriptions. Citation from the interview: "Because, I prescribed an antibiotic and it [the alert] came up and said be aware of kidney failure… So, yeah, I thought it was good." 2. Doctor 5 started to prescribe Fluconazol and received an alert that Fluconazol increases the effect of the anticoagulation medication. As a reaction, he ordered an INR (International Normalized Ratio, a laboratory test measure of blood coagulation) test two days earlier than originally intended. Citation from the interview: ' About Fluconazol and anti-coagulation treatment: it's said that he could have some changes and therefore I change the day where I will take the blood sample -two days ahead instead of four days ahead.' 3. Doctor 5 ordered a drug and received an alert on possible renal insufficiency. As a reaction, she checked the laboratory values and found the patient's renal function to be fine and therefore no further action was taken. Citation from the interview: 'Where it said something about the kidneys, it could have some influence on the kidneys if you have a bad kidney and then I checked the blood sample and kidneys were OK, so I didn't do anything, but otherwise I could have done that, yeah.' 4. Doctor 8 received an alert on an increase of INR by the interaction of cephalosporin and penicillin. As a reaction, he ordered an INR control. 5. Doctor 8 ordered ciprofloxacin and meropenem (two antibiotics) and received an alert. As a reaction, he called his senior colleague to discuss the case. It can be seen that in situation 1 and 5 above, PSIP helped to prevent an error. The other three situations present a way where PSIP helped to reduce an increased risk.
Discussion
Outcome of the simulation study
The quantitative data do not show a clear improvement in performance of the doctors in the PSIP-DK group. However, the qualitative data from observation and interviews highlighted five situations where doctors seem to benefit from alert information provided by the PSIP-DK, most of them being confirmed in the interviews. In two of these situations the PSIP-DK helped to prevent a medication error. A systematic review by Ross et al. (2009) found varying error rate in prescriptions, with newer Research studies in this review showing an error rate of 10-15%. In the PSIP-DK group, approximately 30 prescriptions were to be performed, resulting in 30 situations where prescription-related errors could occur. This would mean that we could expect around three errors (10% of 30 prescriptions) in the PSIP group, with the PSIP-DK helping to prevent two errors and helping to reduce risks for the patient in three other cases. This calculation does not take into account the complexity of the cases and that the cases were selected based on the fact that they had produced real ADEs.
The interviews also showed that most participants found the PSIP-DK to be an interesting approach that should be pursued further. A clear benefit of PSIP-DK compared to the 'standard system' of medication management is the integration of information sources: laboratory data, medication data and diagnosis data into one user interface. Another benefit mentioned by the participants in the interviews is the support provided by the PSIP-DK, especially to young and inexperienced doctors. However, the benefit of support for younger doctors is not directly reflected in the results of the study, where junior doctors did not perform better in the PSIP-DK simulations than in the standard system simulations.
Complexity of the patient cases
The majority of patient cases were considered complicated from the doctor's perspective. All test patients had presented with different symptoms and also had complicated histories; for example, mechanical/biological heart valves, atrial fibrillation or suspected pulmonary embolism. Most of the participants seem to have found the scenarios and also the simulation setting to be very realistic. One event highlights this: there was one situation where a clinician examined the pulse of a patient and found it to be 'normal'. The nurse intervened, pointing out to the clinician that according to the scenario this patient had an extremely high pulse rate. The clinician took some seconds to recall that this was, in fact, a simulated situation that required this patient to exhibit a high pulse rate as part of the acted role. This shows that the overall situation seemed quite natural. Only one user explicitly stated in the interview that the overall situation was 'too artificial'.
Time pressure during the simulations
While the participants agreed that the scenarios were quite realistic, several of them mentioned that the time pressure was quite high. They stated that, normally, they would take more time to care for these patients. We would estimate that the normal handling of these complex cases would take approximately 10 to 15 minutes per case for an experienced doctor who is short on time, but at least 30 minutes for a junior doctor. This time estimate would include time for preparations (i.e. reviewing the patient record before talking to the patient). This preparation time was not available to the participants during the simulations as the simulation runs were planned for about 20 minutes each.
Some users stated that due to the time pressure, they did not read all information provided by the PSIP-DK in detail. Time pressure was introduced into the simulation to induce situations where participants would make errors that they would not have made if they had sufficient time to read all information and to consult additional information. It is clear that in a study situation like this, users would tend to be very careful before prescribing any drug and would try to do their best, as they knew they were being observed. However, this would mean that the error rate was minimal, which in fact would prevent us from seeing any benefit of warnings presented by the PSIP-DK. So time pressure was needed, even when it meant that not all information was read and consequently not all benefits from the PSIP-DK could be exploited. Future simulations should consider making an allowance for a longer preparation time to more accurately reflect the complexity of a particular case.
Training of participants
Before the simulation, the doctors received a hands-on introduction to the PSIP-DK that lasted 20 to 30 minutes. Due to organisational and time constraints, more time was not available. However, such a short introduction may not have been sufficient, as participants had to handle a new system with a new user interface and new functions. In addition, we experienced technical problems with the PSIP-DK, and some (mostly older) doctors had trouble reading the small font on the screen. Thus some participants felt forced to look in the paper records of the patient instead of checking available data in the PSIP-DK prototype. In several cases the doctors looked in the patients' paper record for blood sample analysis results instead of checking in PSIP-DK. This is obviously a problem because PSIP-DK offers the opportunity to present the doctor with the relevant data in one screen view, including results of blood sample analyses. In future simulation trials it would be advisable to provide participants with more time for hands-on experience with the new system.
Infl uence on the doctors: the role of the helpers
When working under pressure, a doctor would normally quickly define the most important two or three issues for a given patient and also make a list of priorities that were adjusted according to any given change in available information during the conversation. In some of the casescenarios, it seems that the doctors listened too much to the helper (who acted as a nurse) instead of working independently. As the doctors received different levels of support and information from the helper, this may have affected the outcome in relation to the gold standard. In future simulations, more attention must be placed on defining and training the role of the helper, to standardise the level of support they provide.
Research
Stability and performance of PSIP-DK
Although we secured the PSIP-DK setup as best we could with a dedicated server containing the CDSS for each computer with the PSIP-DK client, we experienced several breakdowns that interrupted and delayed the simulations. No complete failure of the system occurred though, and the technicians were able to start the system again within a few minutes. These technical problems supported our decision not to go immediately into a field study. However, the problems also interfered with some simulation runs and limited the possibility to identify an impact of PSIP-DK. For future simulations, it would be good to have more extensive pre-tests of the hardware and software, which was not possible in this case due to time constraints.
Resources needed for the simulation
Overall, the preparation for the simulation took six months, and more than 20 researchers and technicians were involved, as well as ten doctors and five 'patients'. An important part of the preparation involved setting up the test cases, which included the establishment of complete clinical datasets (diagnosis, laboratory values and drugs) for each simulated patient in the systems used in the simulation. These efforts were only possible due to the cooperation of the research partner organisation within the PSIP project. The resources were justified because the simulation study was used to perform different lines of research, including an impact evaluation (as reported in this paper) and a usability evaluation reported previously . In addition, the study provided the opportunity to gather important information on technical issues, such as stability and performance, and to experience and evaluate these issues. The results of the simulation, particularly the impact evaluation, would probably not have been possible in a laboratory study, and a field study would have obviously been too early.
Overall, the collective effort that went into this simulation study was considerable, but the amount and the quality of realistic data that the study generated has also made a considerable contribution to research in this area. However, it has also made it clear that simulation studies do not need fewer resources than field studies; and that they require more resources than a pure laboratory evaluation study.
Conclusion
The simulation study showed that a majority of doctors were in favour of an integrated presentation of clinical data and also of automatic alert functionality. However, technical problems and unfamiliarity with the new PSIP-DK system did not allow identification of differences of the impact of the PSIP-DK compared with the 'standard system'. This should be reinvestigated in future simulation studies with a more advanced PSIP-DK system. The experiences gained from simulation studies show that a simulation is, in general, a useful approach that can yield important insight into potential harmful technologies. However, several issues need to be solved and tested before starting a simulation, including: realistic complexity of cases; a balance of time pressure and time for preparation; sufficient time for training of participants with the new prototype; clear definitions of all roles including the role of helpers; sufficient maturity of the prototype, and sufficient resources for preparing and conducting the simulations.
